The TNYL-RAW peptide has been shown to inhibit EphB4 tyrosine phosphorylation (activation) induced by ephrin-B2 in cultured MCF7 breast cancer cells [33] and human umbilical vein endothelial cells (HUVECs) [36]. This evidence concerns the gene EPHB4 and breast carcinoma.